BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 11961146)

  • 21. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.
    Kung C; Pingel JT; Heikinheimo M; Klemola T; Varkila K; Yoo LI; Vuopala K; Poyhonen M; Uhari M; Rogers M; Speck SH; Chatila T; Thomas ML
    Nat Med; 2000 Mar; 6(3):343-5. PubMed ID: 10700239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
    Hoogerbrugge PM; van Beusechem VW; Fischer A; Debree M; le Deist F; Perignon JL; Morgan G; Gaspar B; Fairbanks LD; Skeoch CH; Moseley A; Harvey M; Levinsky RJ; Valerio D
    Gene Ther; 1996 Feb; 3(2):179-83. PubMed ID: 8867866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
    Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
    Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
    Adjali O; Marodon G; Steinberg M; Mongellaz C; Thomas-Vaslin V; Jacquet C; Taylor N; Klatzmann D
    J Clin Invest; 2005 Aug; 115(8):2287-95. PubMed ID: 16075064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
    Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
    N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
    [No Abstract]   [Full Text] [Related]  

  • 30. Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.
    Tsai EJ; Malech HL; Kirby MR; Hsu AP; Seidel NE; Porada CD; Zanjani ED; Bodine DM; Puck JM
    Blood; 2002 Jul; 100(1):72-9. PubMed ID: 12070011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
    Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
    J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
    Sponzilli I; Notarangelo LD
    Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
    Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
    Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].
    Cartier N; Hacein-Bey-Abina S; Von Kalle C; Bougnères P; Fischer A; Cavazzana-Calvo M; Aubourg P
    Bull Acad Natl Med; 2010 Feb; 194(2):255-64; discussion 264-8. PubMed ID: 21166117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].
    Hacein-Bey S; Gross F; Nusbaum P; Yvon E; Fischer A; Cavazzana-Calvo M
    Pathol Biol (Paris); 2001 Feb; 49(1):57-66. PubMed ID: 11265225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.
    Ting-De Ravin SS; Kennedy DR; Naumann N; Kennedy JS; Choi U; Hartnett BJ; Linton GF; Whiting-Theobald NL; Moore PF; Vernau W; Malech HL; Felsburg PJ
    Blood; 2006 Apr; 107(8):3091-7. PubMed ID: 16384923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy fulfilling its promise.
    Kohn DB; Candotti F
    N Engl J Med; 2009 Jan; 360(5):518-21. PubMed ID: 19179320
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal T-cell engraftment associated with severe hemophagocytosis of the bone marrow in untreated X-linked severe combined immunodeficiency.
    Dvorak CC; Sandford A; Fong A; Cowan MJ; George TI; Lewis DB
    J Pediatr Hematol Oncol; 2008 May; 30(5):396-400. PubMed ID: 18458578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for primary adaptive immune deficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia.
    Ginn SL; Curtin JA; Kramer B; Smyth CM; Wong M; Kakakios A; McCowage GB; Watson D; Alexander SI; Latham M; Cunningham SC; Zheng M; Hobson L; Rowe PB; Fischer A; Cavazzana-Calvo M; Hacein-Bey-Abina S; Alexander IE
    Med J Aust; 2005 May; 182(9):458-63. PubMed ID: 15865589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.